BCYC (STOCKS)
Bicycle Therapeutics plc American Depositary Shares
$5.465000
-0.165000 (-2.93%)
Prev close: $5.630000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Kevin Lee
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $387.13M
- Employees
- 305
- P/E (TTM)
- -1.55
- P/B (TTM)
- 0.63
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
6
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.85 | $-1.10 | +0.2493 | +22.68% |
|
Jun 2025 (Q2)
|
$-1.14 | $-0.97 | -0.1694 | -17.45% |
|
Mar 2025 (Q1)
|
$-0.88 | $-0.86 | -0.0209 | -2.43% |
|
Dec 2024 (Q4)
|
$-0.82 | $-0.88 | +0.0557 | +6.36% |
Financial Statements
| Revenues | $28.34M |
| Benefits Costs and Expenses | $281.19M |
| Costs And Expenses | $281.19M |
| Nonoperating Income/Loss | $37.17M |
| Operating Expenses | $318.36M |
| Depreciation and Amortization | $6.80M |
| Research and Development | $238.29M |
| Other Operating Expenses | $73.27M |
| Operating Income/Loss | -$290.02M |
| Income/Loss From Continuing Operations After Tax | -$250.66M |
| Income/Loss From Continuing Operations Before Tax | -$252.86M |
| Income Tax Expense/Benefit | -$2.20M |
| Income Tax Expense/Benefit, Deferred | -$2.73M |
| Net Income/Loss | -$250.66M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$250.66M |
| Net Income/Loss Available To Common Stockholders, Basic | -$250.66M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.62 |
| Diluted Earnings Per Share | -$3.62 |
| Basic Average Shares | 211,393,803 |
| Diluted Average Shares | 211,393,803 |
| Assets | $763.95M |
| Current Assets | $738.82M |
| Noncurrent Assets | $25.14M |
| Fixed Assets | $6.86M |
| Other Non-current Assets | $18.27M |
| Liabilities | $145.48M |
| Current Liabilities | $69.28M |
| Accounts Payable | $12.65M |
| Wages | $14.88M |
| Other Current Liabilities | $41.75M |
| Noncurrent Liabilities | $76.19M |
| Equity | $618.48M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $618.48M |
| Liabilities And Equity | $763.95M |
| Net Cash Flow From Operating Activities | -$239.73M |
| Net Cash Flow From Operating Activities, Continuing | -$239.73M |
| Net Cash Flow From Investing Activities | -$2.14M |
| Net Cash Flow From Investing Activities, Continuing | -$2.14M |
| Net Cash Flow From Financing Activities | $87.00K |
| Net Cash Flow From Financing Activities, Continuing | $87.00K |
| Net Cash Flow | -$241.78M |
| Net Cash Flow, Continuing | -$241.78M |
| Comprehensive Income/Loss | -$250.95M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$250.95M |
| Other Comprehensive Income/Loss | -$286.00K |